VIXOR

Serial Number 86444112
606

Registration Progress

Application Filed
Nov 4, 2014
Under Examination
Mar 31, 2015
Approved for Publication
Feb 4, 2015
Published for Opposition
Feb 3, 2015
Registered

Basic Information

Serial Number
86444112
Filing Date
November 4, 2014
Published for Opposition
February 3, 2015
Abandonment Date
May 2, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 2, 2016
Classes
005

Rights Holder

Alkermes Pharma Ireland Limited

03
Address
Connaught House
1 Burlington Road
Dublin 4
IE

Ownership History

Alkermes Pharma Ireland Limited

Original Applicant
03
Dublin 4 IE

Alkermes Pharma Ireland Limited

Owner at Publication
03
Dublin 4 IE

Legal Representation

Attorney
Norman J. Rich

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description
May 2, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 2, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 15, 2015 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Sep 14, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 14, 2015 EX1G S SOU EXTENSION 1 GRANTED
Sep 1, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 1, 2015 EXT1 S SOU EXTENSION 1 FILED
Mar 31, 2015 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 4, 2015 NPUB O NOTICE OF PUBLICATION
Feb 3, 2015 PUBO A PUBLISHED FOR OPPOSITION
Jan 28, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 14, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 22, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2014 DOCK D ASSIGNED TO EXAMINER
Nov 14, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005